X0306 4 2020-11-23 0 0001438533 Travere Therapeutics, Inc. RTRX 0001388773 Clague Laura C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300 SAN DIEGO CA 92130 0 1 0 0 Chief Financial Officer Common Stock 2020-11-23 4 A 0 7500 0.00 A 26973 D Common Stock 2020-11-24 4 S 0 3750 23.86 D 23223 D Common Stock 2020-11-25 4 S 0 3750 22.72 D 19473 D On May 17, 2017, the reporting person was granted performance restricted stock units (PRSUs) covering 15,000 shares of the Issuer's common stock, which vest upon the satisfaction of certain performance criteria. On November 23, 2020, a portion of the PRSUs vested upon the Issuer's confirmation of the satisfaction of a performance criterion. The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units. /s/ Elizabeth E. Reed, Attorney-in-Fact 2020-11-25